G. Rosella et al., IMPAIRED GLUCOSE-TOLERANCE AND INCREASED WEIGHT-GAIN IN TRANSGENIC RATS OVEREXPRESSING A NON-INSULIN-RESPONSIVE PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE, Molecular endocrinology, 9(10), 1995, pp. 1396-1404
The effects of an overexpressed, non-insulin-responsive gluconeogenic
enzyme, phosphoenolpyruvate carboxykinase (GTP) (PEPCK; EC 4.1.1.32),
on glucose homeostasis were investigated. Transgenic rats harboring a
metallothionein-driven PEPCK gene (lacking the entire PEPCK upstream-
regulatory region) expressed transgene PEPCK mRNA in the key gluconeog
enic tissues, liver and kidney. Female transgenic rats, studied at 10
weeks of age, showed mild fasting hyperglycemia (6.9 +/- 0.2 vs. 5.9 /- 0.1 mM P = 0.002 n = 6), hyperinsulinemia (92.2 +/- 4.0 vs. 54.0 +/
- 6.6 pM, P = 0.001, n = 6), impaired glucose tolerance and increased
weight gain (178.3 +/- 3.2 vs. 153.4 +/- 2.5 g, P = 0.001, n = 16 and
n = 13 transgenic and control rats, respectively). Despite hyperinsuli
nemia at this age, kidneys of transgenic rats maintained a significant
20% elevation of total PEPCK enzyme activity, while total liver PEPCK
activity was not reduced. This study suggests that an insulin-resista
nt step in the gluconeogenic pathway can lead to glucose intolerance a
nd an increase in weight. These rats offer the unique opportunity to s
tudy the metabolic consequences of chronic, mild excess glucose supply
, as seen in non-insulin-dependent diabetes.